Initial vaccine studies included allogeneic and autologous granulocyte-macrophage colony stimulating factor (GM-CSF)-secreting tumor vaccines for pancreas cancer and melanoma (2, 3). The gene discussed is CSF2; the disease is pancreatic neoplasm.